Azitra (AZTR) to Release Earnings on Monday

Azitra (NYSEAMERICAN:AZTR) is expected to be announcing its Q2 2026 results before the market opens on Monday, August 10th. Analysts expect Azitra to announce earnings of ($0.1150) per share for the quarter. Investors are encouraged to explore the company’s upcoming Q2 2026 earning report for the latest details on the call scheduled for Wednesday, August 12, 2026 at 9:30 AM ET.

Azitra (NYSEAMERICAN:AZTR) last issued its quarterly earnings results on Wednesday, May 13th. The company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.24). On average, analysts expect Azitra to post $-0 EPS for the current fiscal year and $-0 EPS for the next fiscal year.

Azitra Stock Performance

Azitra stock opened at $0.12 on Monday. Azitra has a fifty-two week low of $0.10 and a fifty-two week high of $1.40. The firm’s fifty day moving average price is $0.17 and its 200-day moving average price is $0.21.

Azitra Company Profile

Azitra Inc is a clinical-stage biopharmaceutical company focused on developing live bacterial therapies for dermatological conditions. Headquartered in Cambridge, Massachusetts, the company leverages its proprietary ActoBiotic platform to formulate topical treatments that aim to modulate the skin’s native microbial ecosystem.

The company’s lead investigational therapies are being evaluated in early-phase clinical studies for inflammatory skin disorders, including atopic dermatitis and other conditions characterized by microbial imbalance.